ClotTriever® Thrombectomy System Use-Result Survey in Japan

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06871683

Enrollment

100

Registered

2025-03-12

Start date

2025-02-17

Completion date

2028-12-01

Last updated

2026-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis

Brief summary

The objective of this survey is to determine the safety and efficacy of the ClotTriever Thrombectomy System under daily clinical practice after marketing approval in Japan. This device was designated as a subject of use results evaluation at the time of application for manufacturing and marketing approval.

Interventions

DEVICEClotTriever® Thrombectomy System

ClotTriever® Thrombectomy System use for treatment of patients with deep vein thrombosis with acute severe symptoms.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

This is an all-comers survey of all patients treated with ClotTriever® Thrombectomy System in Japan.

Design outcomes

Primary

Measure	Time frame	Description
Rate of Major Adverse Events	Through 30 days post index procedure.	Rate of Major Adverse Events \[All-cause mortality, Major bleeding, New symptomatic Pulmonary Embolism (PE) documented by Computed Tomography Pulmonary Angiography (CTPA), Rethrombosis of a Target Venous Segment\].
Technical Success	During the index procedure	Thrombus residual volume assessed by the the treating physician using pre- and post-procedure venography to evaluate the success of thrombus removal.

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 27, 2026